Clinical Trials Directory

Trials / Unknown

UnknownNCT02402413

Ultrasound Three-dimensional Characterization of Ovarian Morphology in Women With Polycystic Ovary Syndrome (PCOS)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Cagliari · Academic / Other
Sex
Female
Age
15 Years – 25 Years
Healthy volunteers
Accepted

Summary

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders occurring in women of reproductive age. PCOS is considered a syndrome of ovarian dysfunction that is characterized by the heterogeneous clinical manifestation of infrequent or absent menstrual cycles, hyperandrogenism, and polycystic ovarian morphology. An important ultrasound parameter is the ratio stroma/ovary, the ratio of the volume, evaluated in two-dimensional ultrasound, of the stroma, that secrete androgen, and the ovary. It has been shown that when this ratio is higher than a third the levels of circulating androgens and high. Aim of the present study is to assess whether this ratio, determined with three-dimensional ultrasound, is correlated to the increase of androgens.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasoundThe patients will be subjected to ultrasound bi-dimensional or three-dimensional. Will Be calculated the ratio stroma/volume with both methods
PROCEDUREDetermination of concentrations of androgensDetermination of concentrations of serum levels of circulating androgens
DEVICEThree dimensional ultrasound probeCapture of ovarian three dimensional volumes

Timeline

Start date
2016-06-01
Primary completion
2016-09-01
Completion
2016-12-01
First posted
2015-03-30
Last updated
2016-03-09

Source: ClinicalTrials.gov record NCT02402413. Inclusion in this directory is not an endorsement.